Patents Assigned to NUMAB AG
  • BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DISEASES
    Publication number: 20160368987
    Abstract: The present invention relates to bispecific constructs that specifically bind to cytotoxic T cells and, simultaneously, to IL5R-carrying target cells, as well as nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production and use thereof, including the use of the bispecific constructs in treating inflammatory and/or autoimmune diseases and cancer.
    Type: Application
    Filed: October 24, 2014
    Publication date: December 22, 2016
    Applicant: NUMAB AG
    Inventors: David URECH, Tea GUNDE, Sebastian MEYER
  • NOVEL ANTIBODY FRAMEWORKS
    Publication number: 20160130326
    Abstract: The present invention relates to novel antibody frameworks with advantageous properties.
    Type: Application
    Filed: June 26, 2014
    Publication date: May 12, 2016
    Applicant: NUMAB AG
    Inventors: Sebastian MEYER, David URECH
  • NOVEL ANTIBODIES
    Publication number: 20160090416
    Abstract: The present invention relates to novel antibodies, which combine high affinity with high potency, particularly novel antibodies against a novel epitope.
    Type: Application
    Filed: May 28, 2014
    Publication date: March 31, 2016
    Applicant: NUMAB AG
    Inventors: Tea GUNDE, Sebastian MEYER, David URECH